Stay Connected with ERT:
-
Recent Posts
- Improving Your Drug’s Value Proposition throughout the Product Lifecycle: How Optimized Clinical Outcomes Assessment (COA) Strategies Can Drive Commercialization Success
- Metrics Champion Consortium – Cardiopulmonary Performance Metrics Initiative
- The Importance of Inspiratory Capacity in COPD Clinical Trials
- CLEAR Study Update: A look inside the collaboration between ERT and UCLA
- Brief Report – Changes to the FDA Draft Guidance Suicidal Ideation and Behavior: Prospective Assessment of Occurrence in Clinical Trials
Archives
Monthly Archives: February 2012
Partnerships Series: Strategic vs. Tactical Outsourcing for Pharmaceutical Sponsors
Outsourcing practices have become an increasing trend as the demand for capacity, speed, an expanded geographic footprint, and cost containment continue to grow in the pharmaceutical industry. Other factors leading to project outsourcing are the increasing complexities of clinical trial … Continue reading
